Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients

Thrombosis and Haemostasis

Volumn 78, Issue 4, 1997, Pages 1167-1172

  Kockx, M ^a   De Maat, M P M ^a   Knipscheer, H C ^a   Kastelein, J P ^a   Kluft, C ^a   Princen, H M G ^a   Kooistra, T ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTILIPEMIC AGENT; CHOLESTEROL; CIPROFIBRATE; FIBRINOGEN; GEMFIBROZIL; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030695967     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657709     Document Type: Article

References (44)